Review: Emergomycosis |
| |
| Affiliation: | 1. Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa;2. Division of Infectious Diseases, Department of Internal Medicine, Helen Joseph Hospital, University of the Witwatersrand, Johannesburg, South Africa;3. National Institute for Communicable Diseases, a Division of the National Health Laboratory Service; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa;4. Division of Medical Microbiology, University of Cape Town, South Africa;5. Institute of Infection and Immunity, St George''s University of London, United Kingdom;6. MRC Centre for Medical Mycology, University of Exeter, United Kingdom;1. Centre International de Recherches Médicales de Franceville, BP 769, Franceville, Gabon;2. BCCM/IHEM, Mycology and Aerobiology, Sciensano, Brussels, Belgium;1. Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India;1. Department of Parasitology and Mycology, CHU Toulouse, Toulouse, France;2. Critical Care Unit, University Hospital of Purpan, Toulouse, France;3. Toulouse NeuroImaging Center, Unité Mixte de Recherche 1214, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France;4. Department of Infectious and Tropical Diseases, CHU Toulouse, Toulouse, France;5. PHARMA-Dev, UMR 152 IRD-UPS, Université Toulouse, France;6. Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse, CNRS UMR5051, INSERM UMR1291, UPS, Toulouse, France;7. Neuroradiology Department, Pierre-Paul-Riquet/Purpan University Hospital, Toulouse, France;8. RESTORE Institute, UMR 1301-Inserm 5070-CNRS EFS Univ. P. Sabatier, Toulouse, France;1. Department of Medical Microbiology, Faculty of Medicine, KTO Karatay University, Konya, Turkey;2. Department of Medical Microbiology, Faculty of Medicine, Ni?de Ömer Halisdemir University, Ni?de, Turkey;3. Department of Medical Genetics, Faculty of Medicine, KTO Karatay University, Konya, Turkey;4. Department of Chemistry, Faculty of Science, Gazi University, Ankara, Turkey;5. Department of Medical Pharmacology, Faculty of Medicine, KTO Karatay University, Konya, Turkey;6. Department of Molecular Biology and Genetics, Faculty of Science, Necmettin Erbakan University, Konya, Turkey;1. Department of epidemiology in parasitic diseases, University of Science, Techniques and Technologies of Bamako, Mali;2. Infectious disease and tropical medicine Unit, CHU Point G Bamako, Mali;3. Manchester Fungal Infection Group, Core Technology Facility Grafton Street, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK;4. Global Action for Fungal Infections, Geneva, Switzerland |
| |
| Abstract: | Purpose of Review In this review, we provide an overview of emergomycosis from a clinical perspective and discuss the taxonomy and classification of the pathogens, epidemiology, pathophysiology of infection and mechanisms of pathogenesis, immunology, clinical manifestations, laboratory culture and diagnosis, molecular characterisation, therapy and prognosis.Recent Findings While Emergomyces pasteurianus is the most geographically-widespread species, Emergomyces africanus is endemic to Southern Africa and causes disseminated disease with cutaneous involvement primarily among patients with advanced human immunodeficiency virus (HIV) disease.Summary Emergomycosis, a disseminated clinical disease resulting from infection with dimorphic fungi in the genus Emergomyces, occurs primarily among immunocompromised patients. Further knowledge is needed on the pathophysiology, diagnosis and management of emergomycosis. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
